Home

Cohance Lifesciences Ltd 52 Week Low

Image

Cohance Lifesciences Ltd

NSE: COHANCE

YEARLOW

₹ 789.1

Last updated on: Jul 08, 2025

Key Highlights

  • The 52 Week Low of Cohance Lifesciences Ltd is ₹ 789.1 as of 08 Jul 25 .

Company Fundamentals for Cohance Lifesciences Ltd

Market Price of Cohance Lifesciences Ltd

1M

1Y

3Y

5Y

Monitoring Cohance Lifesciences Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPrice (₹)right
08 Jul 2025990.45
07 Jul 20251018.75
04 Jul 20251043.8
03 Jul 20251006.65
02 Jul 2025967.4
01 Jul 2025960.35
30 Jun 2025966.65
27 Jun 2025944.05
26 Jun 20251002.1
25 Jun 2025980

Asset Value vs Market Value of Cohance Lifesciences Ltd

Market Value

0

Asset Value

0

* All values are in ₹ crores

Historical Revenue of Cohance Lifesciences Ltd

No data available

* All values are in crore

Historical Net Profit of Cohance Lifesciences Ltd

No data available

* All values are in crore

Cohance Lifesciences Ltd News Hub

Suven Pharmaceuticals consolidated net profit declines 49.61% in the June 2024 quarter

Net profit of Suven Pharmaceuticals declined 49.61% to Rs 60.77 crore in the quarter ended June 2024

Read more

09 Aug 24

Suven Pharmaceuticals to hold board meeting

Suven Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 9 August 2024.

Read more

06 Aug 24

Suven Pharmaceuticals appoints Vivek Sharma as new Executive Chairman

Suven Pharmaceuticals announced the appointment of Vivek Sharma as the new Executive Chairman, effec

Read more

19 Sept 24

Board of Suven Pharmaceuticals approves change in Executive Chairperson

The Board of Suven Pharmaceuticals at its meeting held on 19 September 2024 has taken on record the

Read more

19 Sept 24

Document

Annual Reports

N/A

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

Data not available

FAQs for 52 Week Low of Cohance Lifesciences Ltd

Why is it important to track the 52-week low of Cohance Lifesciences Ltd stocks?

Investors should monitor the 52-week low of Cohance Lifesciences Ltd stocks regularly to stay informed about significant price changes and assess the stock's performance over time. Frequent monitoring will help traders identify trends and make timely decisions.

What factors can lead to Cohance Lifesciences Ltd stocks hitting a 52-week low?

Factors leading to Cohance Lifesciences Ltd stocks hitting a 52-week low may include poor fiscal results, negative industry trends, macroeconomic issues, or management changes. Other factors such as market volatility and broader economic downturns can also contribute to a 52-week low.

Should investors buy Cohance Lifesciences Ltd stocks when they hit a 52-week low?

Buying Cohance Lifesciences Ltd stocks at a 52-week low can offer a potential bargain, however, it is crucial to evaluate the reasons behind the stock price drop and ensure there is no underlying fundamental issue. Investors should consider the company's long-term prospects before making a buying decision.

How often should investors monitor the 52-week low of Cohance Lifesciences Ltd stocks?

Investors should monitor the 52-week low of Cohance Lifesciences Ltd stocks regularly to stay informed about significant price changes and assess the stock's performance over time, which will help them identify trends and make timely decisions.

How can an investor assess the risk of buying Cohance Lifesciences Ltd stock at their 52-week low?

An investor can analyze the reasons for the Cohance Lifesciences Ltd stock price drop, evaluate the company’s fundamentals, and consider market conditions. Investors should also review the stock’s historical performance and any potential recovery indicators.

Should investors consider the overall market trend when evaluating Cohance Lifesciences Ltd stocks at their 52-week low?

Certainly, considering the overall market trend when evaluating Cohance Lifesciences Ltd stocks at their 52-week low is significant as it provides context for the stock’s performance and potential future movements. A declining market trend may influence Cohance Lifesciences Ltd stock performance, impacting the timing and potential of the investment.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions